JEIL PHARMA HOLDINGS INC.
Develops and distributes APIs, generics, and modified drugs, specializing in injections.
002620 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002620003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 사평대로 343, 서초구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Jeil Pharma Holdings Inc. is a holding company that operates in the pharmaceutical industry. Through its subsidiaries, primarily Jeil Pharmaceutical Co., Ltd. (founded in 1959), the company manufactures and distributes a wide range of pharmaceutical products. Its business encompasses the production of active pharmaceutical ingredients (APIs), generic drugs, and incrementally modified drugs. The company's portfolio includes treatments across various therapeutic areas such as analgesic anti-inflammatories, antibiotics, anticoagulants, anti-diabetics, and gastrointestinal medicines. Jeil focuses on developing new synthetic processes and high-value products, with a specialization in injection medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-05-29 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 923.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.7 MB | ||
| 2025-03-25 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 20.7 KB | ||
| 2025-03-17 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 21.4 KB | ||
| 2025-03-17 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 2.0 MB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 987.3 KB | ||
| 2025-03-05 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 9.1 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 8.6 KB | ||
| 2025-02-24 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.3 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 1.5 MB | ||
| 2024-09-23 00:00 |
Governance Information
[기재정정]기업지배구조보고서공시
|
Korean | 847.3 KB | ||
| 2024-08-28 00:00 |
Interim Report
[기재정정]반기보고서 (2024.06)
|
Korean | 1.4 MB | ||
| 2024-08-14 00:00 |
Interim Report
반기보고서 (2024.06)
|
Korean | 1.4 MB | ||
| 2024-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 844.4 KB |
Automate Your Workflow. Get a real-time feed of all JEIL PHARMA HOLDINGS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for JEIL PHARMA HOLDINGS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for JEIL PHARMA HOLDINGS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Inc./other/Mind_Medicine_MindMed_Inc.-logo.png){kind=logo}
